In This Section

AACR COVID-19 and Cancer Meeting to Feature Anthony Fauci as Keynote Speaker

The American Association for Cancer Research (AACR) will host a virtual meeting on COVID-19 and cancer July 20-22, 2020. Registration is complimentary for credentialed members of the media. Contact Kathleen Venango at [email protected]org to register.

Speaker Highlights

The AACR Virtual Meeting: COVID-19 and Cancer will feature presentations from government officials, academics, and industry leaders who are on the cutting edge of research related to COVID-19 and cancer. Highlights include:


Monday, July 20

  • Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, will present a keynote address titled “Coronavirus infections: More than just the common cold” at 10 a.m. ET.
  • Benjamin tenOever, PhD, Icahn School of Medicine at Mount Sinai, will present a talk titled “The crosstalk between cellular transformation and the response to SARS-CoV-2 infection.”
  • Kizzmekia S. Corbett, PhD, National Institute of Allergy and Infectious Diseases, will speak on COVID-19 vaccine development. Her presentation is titled “Rapid SARS-CoV-2 mRNA vaccine development enabled by prototype pathogen preparedness.”
  • Louis M. Staudt, MD, PhD, National Cancer Institute, will present his talk, “Inhibition of Bruton Tyrosine Kinase in patients with severe COVID-19,” during a session on cancer drug repurposing to treat COVID-19.


Tuesday, July 21

  • Solange Peters, MD, PhD, CHU Vaudois, Lausanne, Switzerland, will present a keynote address titled “Flexibility to sustain solidity: Addressing new vulnerabilities in cancer at the time of COVID-19.”
  • Kevan Shokat, PhD, University of California, San Francisco, will present a talk titled “Leveraging new insights from cancer drug discovery to target viral host factors.”
  • Arthur Caplan, PhD, NYU Langone Health, will present a talk titled “Ethics, cancer and COVID.”
  • Douglas R. Lowy, MD, National Cancer Institute, will discuss COVID-19 diagnostics development in a presentation titled “When cancer research goes viral.”
  • Patrick D. Hsu, PhD, University of California, Berkeley, will discuss CRISPR tests for the virus.


Wednesday, July 22

  • John M. Carethers, MD, University of Michigan, will discuss cancer health disparities and COVID-19.
  • Otis W. Brawley, MD, Johns Hopkins University, will present a talk on cancer prevention and early detection during the pandemic.
  • Trevor Bedford, PhD, Fred Hutchinson Cancer Research Center, will give a keynote address on genomic tracking of the virus’s evolution and spread.
  • Norman E. Sharpless, MD, director of the National Cancer Institute, will offer remarks and participate in a closing roundtable with AACR President Antoni Ribas, MD, PhD; AACR President-Elect David A. Tuveson, PhD, and AACR Past President (2018-2019) Elizabeth M. Jaffee, MD.

Session Highlights

Sessions will include symposia and forums on a wide variety of timely topics.

Meeting Program Chair and AACR President-Elect David A. Tuveson, PhD, will moderate two symposia featuring invited talks and highly rated proffered papers:


SYMPOSIUM 1: INTERSECTION OF THE BIOLOGY SARS-COV-2 AND CANCER
Monday, July 20, 10:50 a.m.-12:50 p.m. ET

  • The crosstalk between cellular transformation and the response to SARS-CoV-2 infection
    Benjamin tenOever, Icahn School of Medicine at Mount Sinai
  • Therapeutic targeting of TMPRSS2 and ACE2 as a potential strategy to combat COVID-19
    Irfan A. Asangani, University of Pennsylvania
  • Optimizing treatment for COVID-19 using computational modelling: Implications for cancer patients
    Lance L. Munn, Harvard Medical School
  • A prediction of prostate cancer deaths spiking by SARS-CoV-2 infection
    Alakesh Bera, Uniformed Services University
  • Systems approaches reveal shared pathways affected in SARS-CoV-2 infection and cancer
    Nevan Krogan, University of California, San Francisco


SYMPOSIUM 8: COVID-19 DIAGNOSTICS DEVELOPMENT
Tuesday, July 21, 2:20-4:20 p.m. ET

  • When cancer research goes viral
    Douglas R. Lowy, National Cancer Institute
  • Highly sensitive and full-genome interrogation of SARS-CoV-2 using multiplexed PCR enrichment followed by next-generation sequencing
    Chenyu Li, Paragon Genomics
  • CRISPR tests for SARS-CoV-2
    Patrick D. Hsu, University of California, Berkeley
  • Rapid isothermal SARS-CoV-2 detection using RT-LAMP 
    Brian Rabe, Harvard Medical School


Forums featuring conversations among leading experts will include:

  • Regulatory and Operational Implications of Cancer Clinical Trial Changes During COVID-19
  • Telehealth
  • How Will We Bring Patients Back to the Clinic?
  • How Cancer Researchers Are Applying Their Talents to COVID-19 Issues
  • Public-Private Partnerships Poised to Address COVID-19
  • Health Disparities


The full program is available here.


Additional Details

Contact Julia Gunther at [email protected] or 770-403-7690, or Matthew Burns at [email protected] or 610-618-0666, to schedule interviews with presenters or meeting organizers.

To register as press or for help accessing the virtual meeting platform, please contact Kathleen Venango at [email protected].